MAL2 and breast carcinoma: Studies have confirmed that MAL2 inhibits the presentation of tumor antigens by directly interacting with MHC-I complexes to promote the endocytosis of tumor antigens, thereby promoting the immune escape of breast cancer cells [56, 57].